KRAS Gene Polymorphisms and their Impact on Breast Cancer Risk in an Iranian Population

about

Detection of a 4-bp Insertion/deletion Polymorphism within the Promoter of EGLN2 Using Mismatch PCR-RFLP and Its Association with Susceptibility to Breast Cancer

P2860

Q54091121-8C6483C4-8A63-480D-9D34-6EFC0F9B4335

P2860

KRAS Gene Polymorphisms and their Impact on Breast Cancer Risk in an Iranian Population

Item

http://www.wikidata.org/entity/Q41381748

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

KRAS Gene Polymorphisms and their Impact on Breast Cancer Risk in an Iranian Population

@en

type

Item

label

KRAS Gene Polymorphisms and their Impact on Breast Cancer Risk in an Iranian Population

@en

prefLabel

KRAS Gene Polymorphisms and their Impact on Breast Cancer Risk in an Iranian Population

@en

P1476

KRAS Gene Polymorphisms and their Impact on Breast Cancer Risk in an Iranian Population

@en

P2093

Ebrahim Eskandari

http://www.w3.org/2001/XMLSchema#string

Gholamreza Bahari

http://www.w3.org/2001/XMLSchema#string

Mohammad Hashemi

http://www.w3.org/2001/XMLSchema#string

Sara Sanaei

http://www.w3.org/2001/XMLSchema#string

Seyed Mehdi Hashemi

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)

A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk

A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

The let-7 microRNA represses cell proliferation pathways in human cells

The KRAS-variant is associated with risk of developing double primary breast and ovarian cancer

Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area and California women: 1988 to 2004.

A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk.

The involvement of Kras gene 3'-UTR polymorphisms in risk of cancer and influence on patient response to anti-EGFR therapy in metastatic colorectal cancer: a meta-analysis.

KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study.

Functional polymorphisms of FAS and FASL gene and risk of breast cancer - pilot study of 134 cases.

P304

1301-1305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.22034/APJCP.2017.18.5.1301

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28610418

http://www.w3.org/2001/XMLSchema#string

P932

5555539

http://www.w3.org/2001/XMLSchema#string

KRAS Gene Polymorphisms and their Impact on Breast Cancer Risk in an Iranian Population

about

P2860

P2860

KRAS Gene Polymorphisms and their Impact on Breast Cancer Risk in an Iranian Population

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932